SPONSOR:PRINTER'S NO.

Sen.1564 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE RESOLUTION Session of No.

Poore220 &2025 Rep.INTRODUCED BY DELLOSO, WAXMAN, SCHLOSSBERG, VENKAT, HILL-EVANS, KAZEEM, PROBST, SANCHEZ AND NEILSON, APRIL 30, 2025 REFERRED TO COMMITTEE ON HUMAN SERVICES, MAY 1, 2025 A RESOLUTION Designating the week of May 4 through 10, 2025, as "Tardive Dyskinesia Awareness Week" in Pennsylvania.

Minor-BrownWHEREAS, Sens.Many people with serious mental health conditions, such as bipolar disorder, major depressive disorder, schizophrenia and schizoaffective disorder, or with gastrointestinal disorders, including gastroparesis, upset stomach, nausea and vomiting, may be treated with medications that work as dopamine receptor blocking agents (DRBAs), including antipsychotics and antiemetics;

Hansen,and Pinkney;WHEREAS, While ongoing treatment with these medications can be necessary, prolonged use is associated with tardive dyskinesia (TD), an involuntary movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso, limbs, fingers or toes;

Reps.and WHEREAS, Even mild symptoms of TD can impact people physically, socially and emotionally;

Briggsand King,WHEREAS, Griffith,It K.is estimated that TD affects approximately 800,000 people in the United States and approximately 60% of people with TD have not been diagnosed, making it important to raise awareness about the symptoms;

Johnsonand DELAWAREWHEREAS, STATEIt SENATEis 152ndimportant GENERALthat ASSEMBLYpeople SENATEtaking CONCURRENTDRBA RESOLUTIONmedication NO.be monitored for TD by a health care provider;

33and DESIGNATINGWHEREAS, MAYThe 1–7,American 2023,Psychiatric ASAssociation “TARDIVErecommends DYSKINESIAregular AWARENESSscreenings WEEK”for INTD; DELAWARE.

and WHEREAS, MayClinical isresearch Nationalhas Mentalled Healthto Awarenessapproval Month;of treatments for adults with TD by the United States Food and Drug Administration;

and WHEREAS, TardiveRecognition Dyskinesiaand istreatment aof movementTD disordercan thatmake disproportionatelya affectspositive peopleimpact beingin treatedthe forlives chronicof mentalmany healthpeople conditions,experiencing includingpsychotic schizophrenia, bipolar disorder, and severemood depression;disorders;

and WHEREAS, ongoingThe treatmentHouse withof prescriptionRepresentatives antipsychoticwants medicationsto hasraise manyawareness benefitsof forTD thoseamong withthe thesepublic and othermedical mentalcommunity; illnesses;

andtherefore WHEREAS,be antipsychoticit medicationsRESOLVED, mayThat leadthe toHouse Tardiveof DyskinesiaRepresentatives indesignate onethe outweek of everyMay four4 patientsthrough receiving10, long-term2025, treatment;as "Tardive Dyskinesia Awareness Week" in Pennsylvania;

and WHEREAS,be Tardiveit Dyskinesiafurther isRESOLVED, characterizedThat bythe random,House involuntary,of andRepresentatives uncontrollableencourage movementspeople ofin musclesthis inCommonwealth and across the face,United trunk,States to become better informed about and extremities;aware of tardive dyskinesia.

and20250HR0220PN1564 WHEREAS,- Tardive2 Dyskinesia- can develop long after a person begins treatment, or even after the discontinuation of treatment with antipsychotic medications;

and WHEREAS, once Tardive Dyskinesia develops, it is often permanent;

and WHEREAS, over 600,000 Americans have been diagnosed with Tardive Dyskinesia, with many more suffering, although unaware of the cause or having been misdiagnosed;

and WHEREAS, scientific breakthroughs and years of research have allowed the Food and Drug Administration to recently approve two new treatments for the symptoms related to Tardive Dyskinesia;

and WHEREAS, it is important to raise further awareness of this disorder throughout the community.

NOW, THEREFORE:

BE IT RESOLVED by the Senate of the 152nd General Assembly of the State of Delaware, the House of Representatives concurring therein, that the week of May 1-7, 2023, is designated as “Tardive Dyskinesia Awareness Week” in the State of Delaware.

BE IT FURTHER RESOLVED that this General Assembly encourages all Delawareans to become better informed about Tardive Dyskinesia.

SD :

AVP :

CBK Page 1 of 2 Released:

04/05/2023 02:16 PM SYNOPSIS This resolution designates the week of May 1-7, 2023, as "Tardive Dyskinesia Awareness Week" in Delaware.

Author:

Senator Poore SD :

AVP :

CBK Page 2 of 2 Released:

04/05/2023 02:16 PM 4761520022